Results (4261)
Real World Outcomes of Patients Treated with Vericiguat in German Routine Care (ROVER)
Germany
EU PAS number:
EUPAS1000000221
First published:
14/04/2025
StudyOngoing
Implementation of controlled access to and distribution of medicinal products in European Union (CONTROL-EU)
Austria
Greece
Latvia
Netherlands
Portugal
Slovenia
Spain
Sweden
EU PAS number:
EUPAS1000000313
First published:
14/04/2025
StudyPlanned
Non-interventional prospective study in patients with pulmonary fibrosis treated with nintedanib participating in a patient support program in Spain, to describe patient satisfaction with the program and to monitor quality of life. BALANCE Study
Spain
EU PAS number:
EUPAS1000000550
First published:
14/04/2025
StudyPlanned
Alpelisib (Piqray®) Post-Authorization Safety Study (PASS): a non-interventional study of alpelisib in combination with fulvestrant in postmenopausal women, and men, with hormone receptor positive (HR+), human epidermal growth factor receptor 2 negative (HER2-), locally advanced or metastatic breast cancer with a phosphatidylinositol-3-kinase catalytic subunit alpha (PIK3CA) mutation, in the real-world setting
Austria
Croatia
Czechia
Denmark
Finland
Greece
Hungary
Italy
Netherlands
Norway
Poland
Slovenia
Spain
Sweden
EU PAS number:
EUPAS41010
First published:
14/04/2025
StudyDiscontinued
A Retrospective, Non-interventional, Multi-centre Study of TEGSEDI-treated Patients to Evaluate Real-world Adherence to, and Effectiveness of the Recommendations for Platelet Monitoring, Dose Adjustment, and Steroid Initiation to Manage Risk of Thrombocytopenia (TEG4002)
Austria
Bulgaria
Cyprus
France
Germany
Greece
Italy
Portugal
Spain
Sweden
United Kingdom
EU PAS number:
EUPAS37731
First published:
14/04/2025
StudyOngoing
A Prospective Active Surveillance Study to Monitor Growth, Development, and Maturation Among Adolescents with Atopic Dermatitis Exposed to Abrocitinib
Canada
European Union
United States
EU PAS number:
EUPAS1000000515
First published:
14/04/2025
StudyPlanned
Paternal exposure to valproate and the risk of neurodevelopmental disorders in children
Norway
Taiwan
EU PAS number:
EUPAS1000000417
First published:
14/04/2025
StudyOngoing
Postauthorisation Safety Study (PASS) of Avatrombopag in Patients With Severe Chronic Liver Disease (CLD)
Austria
Denmark
Netherlands
Spain
EU PAS number:
EUPAS1000000310
First published:
14/04/2025
StudyPlanned
Comparative assessment of venous thromboembolism and other risks among patients with rheumatoid arthritis treated with baricitinib versus tumor necrosis factor inhibitors - French part of the study program (Safety Outcomes in Patients Treated for RA)
France
EU PAS number:
EUPAS34204
First published:
11/04/2025
StudyFinalised
French Epidemiological Strategy and Medical Economics Metastatic Breast Cancer (ESME-MBC) Database
First published:
11/04/2025
France
Data source
Human
Cancer registryBarzilai Governmental Medical Center, part of Nationwide network (Kineret)
First published:
11/04/2025
Israel
Data source
Human
Emergency care discharge recordsHospital inpatient recordsHospital outpatient visit recordsOtherBnei Zion Governmental Medical Center, part of Nationwide network (Kineret)
Israel
First published:
11/04/2025
InstitutionHospital/Clinic/Other health care facilityENCePP partner
Observational Cohort Study of Zavegepant Safety in Pregnancy within a US Claims Database
United States
EU PAS number:
EUPAS1000000408
First published:
11/04/2025
StudyOngoing
Real-life data study of the French cohort of patients with Rendu Osler disease treatment with bevacizumab:the CoBevaRO study.
France
EU PAS number:
EUPAS1000000548
First published:
11/04/2025
StudyOngoing
DARWIN EU® - Clozapine and the incidence of agranulocytosis over time
Croatia
Denmark
Finland
Germany
Spain
EU PAS number:
EUPAS1000000549
First published:
11/04/2025
StudyOngoing
Tzafon Governmental Medical Center, part of Nationwide network (Kineret)
First published:
11/04/2025
Israel
Data source
Human
Emergency care discharge recordsHospital inpatient recordsHospital outpatient visit recordsOtherShamir Governmental Medical Center, part of Nationwide network (Kineret)
First published:
11/04/2025
Israel
Data source
Human
Emergency care discharge recordsHospital inpatient recordsHospital outpatient visit recordsOtherClinical Investigation and research for the Rendu Osler Cohort
First published:
11/04/2025
Denmark
France
Germany
Italy
Data source
Human
Disease registryDrug registryDARWIN EU® - Use of antiretroviral therapies in paediatric patients
Germany
Norway
Spain
United Kingdom
EU PAS number:
EUPAS1000000545
First published:
10/04/2025
StudyOngoing
An observational, multicenter, prospective, phase IV study evaluating cladribine tablets’ effects on PROs and their correlation with clinical and biometric parameters using Health Technology in subjects with highly-active RMS at their first switch (CLADFIT-MS)
Italy
EU PAS number:
EUPAS43893
First published:
10/04/2025
StudyOngoing
DARWIN EU® – Utilisation of commonly used benzodiazepines during pregnancy and the incidence of pregnancy losses
Norway
Spain
EU PAS number:
EUPAS1000000536
First published:
10/04/2025
StudyOngoing
Registry study to assess the long-term safety of patients with B lymphocyte malignancies treated with tisagenlecleucel
Australia
Austria
Belgium
Canada
Croatia
Czechia
Denmark
Finland
France
Germany
Greece
Israel
Italy
Korea, Republic of
Netherlands
Norway
Poland
Spain
Switzerland
Taiwan
United Kingdom
United States
EU PAS number:
EUPAS32497
First published:
10/04/2025
StudyOngoing
Comparative effectiveness and safety studies using the target trial emulation and estimand frameworks (TARGET-EU)
Belgium
Denmark
Finland
Italy
Netherlands
Norway
Spain
United Kingdom
EU PAS number:
EUPAS1000000539
First published:
10/04/2025
StudyPlanned
C1 inhibitor Treatment Registry to assess the Safety and Immunological Profile of Ruconest in the treatment of HAE Attacks (Ruconest Registry)
Bulgaria
Croatia
France
Germany
Hungary
Italy
Norway
Poland
Slovakia
Slovenia
Sweden
EU PAS number:
EUPAS7375
First published:
10/04/2025
StudyFinalised
Hospices Civils de Lyon (HCL)
France
First published:
09/04/2025
InstitutionEducational InstitutionHealthcare Professional Organisation/Association/Learning SocietyHospital/Clinic/Other health care facility
Periodic Knowledge, Attitudes, and Behavior (KAB) Survey of Certified Prescribers to Assess Understanding of the Risks with the Prolia Risk Evaluation and Mitigation of Strategy (REMS) (20240121)
United States
EU PAS number:
EUPAS1000000393
First published:
09/04/2025
StudyOngoing
Impairment of cognitive, mental and physical functioning in patients after intensive care unit (ICU) stay - Post-intensive care syndrome (PICS-POZ)
Poland
EU PAS number:
EUPAS1000000544
First published:
09/04/2025
StudyOngoing
REpositioning of Medications IN Dementia (REMIND)
France
EU PAS number:
EUPAS1000000484
First published:
09/04/2025
StudyPlanned
Uso de fármacos en mujeres embarazadas y lactantes. Consecuencias en la salud de estas mujeres y en la de su descendencia (Drug use in pregnant and breastfeeding women. Outcomes in the health of the women and the offspring) (Drug use during pregnancy and breastfeeding)
Spain
EU PAS number:
EUPAS47450
First published:
09/04/2025
StudyFinalised
Risks of pharmacological interactions of direct oral anticoagulants: thrombotic and hemorrhagic events leading to hospital admission in Catalonia. (IFACOD)
Spain
EU PAS number:
EUPAS48017
First published:
09/04/2025
StudyPlanned
Association between previous biologic therapy exposure and incidence of life-threatening infections in patients with rheumatoid arthritis and psoriasis. A population-based cohort study.
Spain
EU PAS number:
EUPAS1000000543
First published:
09/04/2025
StudyPlanned
Economic evaluation of Prostatic Urethral Lift (Urolift) (ECOLIFT)
France
EU PAS number:
EUPAS33766
First published:
09/04/2025
StudyOngoing
An Observational, Multinational, Post-Marketing Registry of Omaveloxolone-Treated Patients With Friedreich’s Ataxia
Austria
Czechia
Germany
United States
EU PAS number:
EUPAS1000000196
First published:
08/04/2025
StudyOngoing
Comparing Weight Gain on F/TAF and Placebo Using DISCOVER and iPrEx Study Data
Austria
Brazil
Canada
Denmark
Ecuador
France
Germany
Ireland
Italy
Netherlands
Peru
South Africa
Spain
Thailand
United Kingdom
United States
EU PAS number:
EUPAS1000000509
First published:
08/04/2025
StudyPlanned
VAC4EU Postauthorisation Effectiveness Study of BIMERVAX® Vaccine in Europe
Spain
EU PAS number:
EUPAS1000000337
First published:
08/04/2025
StudyPlanned
VAC4EU Postauthorisation Safety Study of BIMERVAX® Vaccine in Europe
Spain
EU PAS number:
EUPAS1000000321
First published:
08/04/2025
StudyPlanned
A retrospective observational chart review study to evaluate the clinical effectiveness of treatment with zanamivir 10 mg/ml solution for infusion in a cohort of intensive care unit-treated (ICU) patients with complicated influenza infection (208165)
Netherlands
United Kingdom
EU PAS number:
EUPAS37605
First published:
07/04/2025
StudyOngoing
An Open Label, Observational, Prospective Registry of Participants With Sickle Cell Disease (SCD) Treated With Oxbryta® (Voxelotor)® (Voxelotor)
United States
EU PAS number:
EUPAS1000000170
First published:
07/04/2025
StudyFinalised